Long-Term Safety Follow-Up

Long-term Safety Follow-up

POTELIGEO® (mogamulizumab-kpkc)

Dr Roy Fleischmann: ‘Long-term safety of sarilumab in rheumatoid arthritis'

Oxford Academic (Oxford University Press)

Updated analysis of the MAIA trial: long-term safety and efficacy data

VJHemOnc – Video Journal of Hematology & HemOnc

Long-Term Safety of Ketogenic Diets - with Dr. Bret Scher

Long-term pooled safety of guselkumab in patients with moderate-to-severe psoriasis, Lebwohl et al

British Journal of Dermatology

Long-term safety and durable efficacy of esketamine in TRD and ESCAPE-TRD

Ketamine International Journal Club and Conference

MCL: Long-Term Safety/Efficacy Data With Ibrutinib

Ponatinib Efficacy and Safety With the T315I Mutation: Long-Term Follow-up of Phase 1&2 Trials

Duke-led study suggests less invasive way to treat early breast cancer

SAkura: long-term safety and efficacy of satralizumab for NMOSD

Results of the Long-Term Outcomes Study of Ibogaine Treatment in Mexico - Thomas Kingsley Brown

MAPS

Long-term safety and efficacy of sarilumab plus methotrexate

KEYNOTE-716: long-term efficacy and safety of pembrolizumab in resected melanoma

Navigating the Patient Journey From CIDP Diagnosis to Initial Treatment and Long-Term Maintenance

HFA 2023: BeAT-HF: Long-Term Safety Profile and Outcomes by Dr. Faiez Zannad

CVRx | Barostim

Long-term efficacy and safety of pegcetacoplan - GALE Trial

Macular Degeneration Foundation

Long-term safety of niraparib maintenance treatment in patients with recurrent ovarian cancer

Long-term safety analysis of pirtobrutinib in R/R B-cell malignancies

VJHemOnc – Video Journal of Hematology & HemOnc

Long-term safety of momelotinib for myelofibrosis

VJHemOnc – Video Journal of Hematology & HemOnc

Long-term safety and efficacy of tolebrutinib for relapsing multiple sclerosis